Last updated on October 2017

Study for Pediatric ADHD


Brief description of study

Study for Pediatric ADHD

Detailed Study Description

Study for Pediatric ADHD

Learning that your [4 to 12] [4 or 5] year old child has attention-deficit/hyperactivity disorder (ADHD) is challenging. It may leave you wondering what options are available for your child and whether they will be safe for your child at such a young age.

New clinical research studies will evaluate whether an investigational drug is safe and effective in children ages [4 to 12] [4 and 5].

What is the purpose of the clinical research studies?

The studies will evaluate whether the study investigational drug is safe and effective in children with ADHD who are [4 to 12] [4 and 5] years old. Different doses of the investigational drug will also be evaluated.

Who can participate?

With your permission as a parent or legal guardian, your child may qualify for a study if he or she is [4 to 12] [4 or 5] years old and has ADHD symptoms such as increased levels of hyperactivity, inattentiveness, or impulsiveness.

There are other requirements for participation in a study that the study doctor and staff will explain to you in detail during the informed consent process.

To learn more or to see if your child may be eligible to participate in a study, visit www.ADHDKidsStudy.com

Clinical Study Identifier: TX153644

Contact Investigators or Research Sites near you

Start Over

Research Center

Research Center
Houston, TX USA
  Connect »

Research Center

Research Center
Mt. Pleasant, SC USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.